Share-Based Payments: (Tables)

9 Months Ended

Sep. 30, 2024

Equity:

The following table sets forth information with respect to nonvested options for the three months ended March 31, 2024:

The following table sets forth information with respect to nonvested options for the nine months ended September 30, 2024:

	Number of Shares			Weighted Average Grant-Date Fair Value
Nonvested options – beginning of period		122,100		$	24.47
Nonvested options granted		—			—
Nonvested options vested or forfeited		(3,380	)	$	12.02
Nonvested options – end of period		118,720		$	24.83

The following table summarizes stock option information as of March 31, 2024:

The following table summarizes stock option information as of September 30, 2024:

	Shares			Weighted Average Exercise Price
Outstanding at January 1, 2024		308,970		$	86.52
Options forfeited		(380	)		73.09
Options exercised		(24,920	)		69.39
Outstanding at September 30, 2024		283,670		$	88.04
Options exercisable		164,950		$	70.69
Options available for future grants		537,745

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the three months ended March 31, 2024 and 2023 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the nine months ended September 30, 2024 and 2023 were as follows:

(In thousands)	September 30, 2024		September 30, 2023
Cash proceeds from stock options exercised	$	1,729	$	5,523
Tax benefits		272		900
Intrinsic value of stock options exercised		1,721		6,135